English
Specials
Upgrade

Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Get App Open
In App
Open App

LIVE COVERAGE AND VIDEO PARTNERS

Lenovo Tech Today India Prestige Group Acer India ENO

PARTNERS

Tata AIA Life Insurance
Hafele
Motilal Oswal
SMC Global Securities Limited
SBI Life
DSP Mutual Fund
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Kappac Pharma Ltd.

Sector: Pharmaceuticals
Add to
Stock not traded in BSE.
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
MC Essentials
29% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          i  VWAP 0.00
          Beta
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Face Value 0.00
          Mkt Cap (Rs. Cr.) 0
          Dividend Yield --
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Sector PE 0.00
          Book Value Per Share --

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • Mid Range Momentum - Stock is Mid Range compared to Short, Medium and Long Term Moving Averages

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison

          Shareholding Pattern
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Historical Prices
          Volume Analysis

          News

          Kappac Pharma's board meeting on November 13, 2017

          Kappac Pharma's board meeting on November 13, 2017

          Oct 31 2017 02:10 PM

          ₹ Earning + See More

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.
          Powered by Powered by Trendlyne

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          No Data For Substantial Acquisition of Shares & Takeovers.

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Corporate Action

          • No Data For Announcement.
          + See More
          Date Agenda
          + See More
          Ex-Date Type Dividend (Rs)
          + See More
          Announcement Date Ex-Bonus Ratio
          + See More
          Ex-Split Old FV New FV
          + See More
          Ex-Right Ratio Premium
          + See More
          Date Agenda
          + See More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary

          No Data For Summary.

          Trend
          Insights

          No Data For Institutional Holder Analysis.

          • No Data For Insight.

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Kappac Pharma 112.85 - 341.54 - 10.01 -6.44 - -2 0 0.00
          Suyog Gurbaxani 49.45 - 122.94 - 12.46 -70.22 6.34 -6 8 6.88
          Lucent Ind. 37.60 - 56.40 - 3.87 -0.41 - 0 0 0.26
          Gateway Dist-RE 14.00 - 22.53 - - -0.41 - 0 0 0.26
          Net Pix 35.00 - 11.20 - 1.90 -4.06 9.38 0 0 0.09
          + See More

          About the Company

          Kappac Pharma Ltd is engaged in the manufacture of pharmaceutical products. The company``s manufacturing unit has the capacity to produce capsules, tablets and syrups.
          {"success":1,"data":{"address":{"address1":"303, Mahajbeen Arched,","address2":"13\/A, Chakala Cross Lane,,Masjid","city":"Mumbai","state":"Maharashtra","pincode":"400003","telephone1":"022-26826287","telephone2":"","fax1":"022-","fax2":"","email":"kappacpharma@yahoo.com","web":"http:\/\/www.kappacpharma.com"},"management":[{"name":"Arun Vaghasiya","designation":"Additional Director"},{"name":"Rakesh Vekariya","designation":"Additional Director"},{"name":"Zahurahmed Fakir","designation":"Additional Director"}],"registrars":{"name":"Adroit Corporate Service (P) Ltd.","address1":"No.19\/20, Jafferbhoy Industrial Estate, \n1st Floor","address2":"","address3":"","address4":"","telephone":"022-42270400, 28596060, 28594060","fax":"022-28503748, 66924438","email":"info@adroitcorporate.com","internet":"http:\/\/www.adroitcorporate.com","city":"Mumbai","state":"Maharashtra","pincode":"400059"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"506938","nseId":"","series":"","isinid":"INE601D01011"}}}

          • Registered Office

          • Registrars

          • Management

            • Arun Vaghasiya

              Additional Director

            • Rakesh Vekariya

              Additional Director

            • Zahurahmed Fakir

              Additional Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              506938

            • NSE:

            • Series

            • ISIN

              INE601D01011

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>